日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial

采用体外激活的外周血淋巴细胞进行过继性细胞转移疗法联合化疗治疗局部晚期或转移性三阴性乳腺癌:ImmunoBreast Ib期临床试验

Gammelgaard, Odd Lilleng; Ehmsen, Sidse; Jylling, Anne Marie Bak; Sandberg, Lene; Kirkin, Alexei F; Kodahl, Annette Raskov; Ditzel, Henrik J

Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo

他汀类药物治疗早期乳腺癌:MASTER试验;一项随机III期、安慰剂对照试验,比较标准(新)辅助治疗联合阿托伐他汀与标准(新)辅助治疗联合安慰剂的疗效

Borgquist, Signe; Jensen, Maj-Britt; Bendorff, Cecilie Linea; Christiansen, Peer; Offersen, Birgitte Vrou; Kodahl, Annette Raskov; Ewertz, Marianne; Jensen, Anders Bonde; Ahern, Thomas P; Cronin-Fenton, Deirdre; Ejlertsen, Bent

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study

针对缺乏循证治疗方案的实体瘤,开展基因组分析并扩大靶向抗癌药物的应用(PRECODE):一项前瞻性、非随机队列研究的研究方案

Hansen, Karin Holmskov; Lyng, Maria Bibi; Kodahl, Annette Raskov; Asmussen, Jon Thor; Arshad, Arman; Petersen, Henrik; Krogh, Lotte; Ehmsen, Sidse; Kristensen, Thomas Kielsgaard; Ditzel, Henrik J

Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study

2-[(18)F]FDG-PET/CT 与 CE-CT 在转移性乳腺癌患者疗效监测中的成本效益比较:一项基于注册登记的比较研究

Naghavi-Behzad, Mohammad; Gerke, Oke; Kodahl, Annette Raskov; Vogsen, Marianne; Asmussen, Jon Thor; Weber, Wolfgang; Hildebrandt, Malene Grubbe; Kidholm, Kristian

ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial

ProTarget:一项基于基因组分析的丹麦全国性靶向癌症治疗临床试验——一项全国性、II期、前瞻性、多药、非随机、开放标签的篮式试验

Kringelbach, Tina; Højgaard, Martin; Rohrberg, Kristoffer; Spanggaard, Iben; Laursen, Britt Elmedal; Ladekarl, Morten; Haslund, Charlotte Aaquist; Harsløf, Laurine; Belcaid, Laila; Gehl, Julie; Søndergaard, Lise; Eefsen, Rikke Løvendahl; Hansen, Karin Holmskov; Kodahl, Annette Raskov; Jensen, Lars Henrik; Holt, Marianne Ingerslev; Oellegaard, Trine Heide; Yde, Christina Westmose; Ahlborn, Lise Barlebo; Lassen, Ulrik

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

转移性乳腺癌的疗效监测:FDG-PET/CT 与 CE-CT 生存时间的比较

Naghavi-Behzad, Mohammad; Vogsen, Marianne; Vester, Rasmus Mølgård; Olsen, Maiken Madsen Bjerregaard; Oltmann, Hjalte; Braad, Poul-Erik; Asmussen, Jon Thor; Gerke, Oke; Vach, Werner; Kidholm, Kristian; Kodahl, Annette Raskov; Weber, Wolfgang; Hildebrandt, Malene Grubbe